secwatch / observer
8-K filed September 10, 2025, 7:59 PM ET ticker ARTL CIK 0001621221
other confidence high sentiment neutral materiality 0.30

Artelo Biosciences amends bylaws; eliminates stockholder written consent, adopts Nevada control share provisions

ARTELO BIOSCIENCES, INC.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ARTELO BIOSCIENCES, INC.: Amended bylaws to change special meeting notice period, eliminate stockholder action by written consent, clarify status as issuing corporation under NRS 78.378-78.3793, and set record date limit of 60 days (effective 2025-09-09).

Change
bylaw amendment
Effective
2025-09-09
Exact text from the filing
On September 9, 2025, the board of directors (the “Board”) of Artelo Biosciences, Inc. (the “Company”) amended the Company’s amended and restated bylaws, as provided in a Certificate of Amendment to Bylaws (the “Bylaws Amendment”), as follows: · The required notice period for special meetings of the Board has been updated, as provided in the Bylaws Amendment; · The right of stockholders to take action without a meeting has been eliminated; · The Bylaws have been updated to provide that the Company shall in all respects be considered an “issuing corporation” for purposes of the provisions of NRS 78.378 to 78.3793 inclusive, irrespective of whether the Company, as of any date, (i) has 200 or more stockholders of record, at least 100 of whom have had addresses in Nevada appearing on the stock ledger of the Company at all times during the 90 days immediately preceding such date, and/or (ii) does business in Nevada directly or through an affiliated corporation; and · The Bylaws have been up
View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

ARTELO BIOSCIENCES, INC. filing history →

Source: SEC EDGAR
accession 0001640334-25-001660
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.